the level of CRP is related to the weight loss percentage treated with BN
Decreased insulin and IGF-1 signaling lowers mTOR activity, shifting the balance toward muscle catabolism [31]
GLP-1 (Glucagon-like peptide-1) medications have gained significant attention in recent years due to their ability to aid in weight loss and improve metabolic health
While GLP-1 costs remain higher than bariatric surgery, retail prices will come down over time, especially in 2032 (when initial patents run out and generics appear), but probably not to the level of Dexatrim, phen-phen and similar blockbuster, yet faddish, weight-loss pills from yesteryear
One comes with monitoring, lab work, and clinical judgment
Artificial intelligence is transforming drug discovery for GLP-1 analogues by rapidly analyzing vast datasets from chemical libraries, preclinical studies, and clinical trials to identify promising molecular candidates